# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001679
Filing Date
2022-05-16
Accepted
2022-05-16 16:31:07
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | syn-20220331x10q.htm iXBRL | 10-Q | 1468375
2 | EX-31.1 | syn-20220331xex31d1.htm | EX-31.1 | 16006
3 | EX-32.1 | syn-20220331xex32d1.htm | EX-32.1 | 7254
4 | GRAPHIC | syn-20220331x10q001.jpg | GRAPHIC | 48432
| Complete submission text file | 0001410578-22-001679.txt |  | 7096539

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | syn-20220331.xsd | EX-101.SCH | 53449
6 | EX-101.CAL | syn-20220331_cal.xml | EX-101.CAL | 49141
7 | EX-101.DEF | syn-20220331_def.xml | EX-101.DEF | 250463
8 | EX-101.LAB | syn-20220331_lab.xml | EX-101.LAB | 405834
9 | EX-101.PRE | syn-20220331_pre.xml | EX-101.PRE | 376754
65 | EXTRACTED XBRL INSTANCE DOCUMENT | syn-20220331x10q_htm.xml | XML | 1195564

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 22929773
SIC: 2834 Pharmaceutical Preparations